Semantic Web Framework for Quantitative Imaging Biomarker Interoperability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for quantitative imaging in healthcare lack effective tools to bridge molecular/cellular and organism-level knowledge, and fail to facilitate the clinical relevance of biomarker readings, leading to clinician data overload and inefficient use of advanced imaging techniques.
Innovation Solution
A system that utilizes semantic web technology to provide quantitative imaging-derived information, enabling decision support informatics tools that optimize interoperability with clinical IT systems, allowing for semantic search and analysis of imaging and non-imaging data across arbitrary ontology hierarchies, and supporting statistical hypothesis testing to determine clinical relevance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If quantitative imaging techniques are used to capture detailed disease pathology, then measurement precision and diagnostic accuracy are improved, but device complexity and data processing requirements increase
Solution Approach 1:
The patent introduces a standardized data representation framework using RDF (Resource Description Framework) and OWL (Web Ontology Language) as intermediary layers between quantitative imaging data and clinical decision support systems. This framework mediates the complexity by providing a uniform structure for storing, sharing, and reasoning about imaging-derived quantities across different platforms and modalities, thereby reducing the burden of handling complex computational data while maintaining high measurement precision
2Measurement precision
If advanced computational techniques are applied to exploit imaging capabilities, then diagnostic accuracy is improved, but ease of operation and workflow integration deteriorate
Solution Approach 1:
The system implements automated decision support that performs computational analysis and reasoning independently. The ontology-based framework automatically infers disease characteristics, risk stratification, and treatment recommendations from quantitative imaging data without requiring manual computational intervention from clinicians. This self-service capability maintains high diagnostic accuracy while preserving workflow efficiency by handling complex computations in the background
3Loss of information
If detailed quantitative imaging data is stored and analyzed, then information completeness is improved, but loss of time in data processing and retrieval increases
Solution Approach 1:
The patent applies preliminary action by pre-structuring quantitative imaging data into a standardized RDF/OWL framework during data acquisition and storage. Disease characteristics, measurements, and relationships are pre-computed and encoded into the ontology structure before clinical queries are made. This preliminary organization enables rapid retrieval and reasoning about complete disease information without time-consuming processing during clinical decision-making
4Adaptability or versatility
If sophisticated computational methods are used to bridge molecular and organism-level knowledge, then adaptability and research utility are improved, but device complexity and implementation difficulty increase
Solution Approach 1:
The patent implements a universal data representation framework using standardized RDF and OWL ontologies that can handle multiple types of data (imaging, molecular, clinical) and multiple reasoning tasks (diagnosis, research, validation) through a single unified system. This multi-functional approach enables the system to bridge molecular and organism-level knowledge while avoiding the complexity of implementing separate specialized systems for each function
Data Source
AI summary
Methods and systems are disclosed for structuring and using information pertinent to in vivo biomarkers, specifically quantitative imaging biomarkers, using semantic web technology for personalized medicine and discovery science. It supports the development and application of statistical evidence at a level of granularity and sophistication more closely tied to the complexity of the disease itself and its underlying biology, including technology linking multiple biological scales, than has previously been eedisclosed. It provides data and computational services to analyze quantitative imaging and non-imaging data, coupled with multi-scale modeling to elucidate pre-symptomatic and clinical disease processes. It may be used to assess technical or analytical performance for its own sake and/or to further annotate the quantitative analysis. It supports statistical hypothesis testing to determine and present analytical performance, determine the clinical relevance and establish to what extent a biomarker is causally rather than coincidentally related in clinical contexts of use.